News about the Enterprise

Jose Esparza Receives Congressional Medal of Merit - April 20, 2012

Congratulations to Jose Esparza, who received the prestigious Congressional Medal of Merit on 19 April in recognition of his distinguished contributions to global health.  

Enterprise Welcomes Bill Snow as Director of Secretariat - April 2, 2012

The Global HIV Vaccine Enterprise Board of Directors appointed Bill Snow to serve as Director of its Secretariat.  Bill has a long and distinguished history in the HIV vaccine field and knows the history of the Enterprise well, having served on its original Council; as Treasurer of the Board when it received its first funding and working with the Gates Foundation vaccine group while it was the Interim Secretariat in Seattle.

AIDS Vaccine 2012 Accepting Satellite Session Applications - March 21, 2012

AIDS Vaccine 2012 is accepting applications for satellite sessions, click here for more information.  And do not forget to submit your abstracts and scholarship applications by the 6 April deadline.

AIDS Vaccine 2012 Abstract and Scholarship Deadline is April 6 - March 5, 2012

AIDS Vaccine 2012 is accepting abstract submissions and scholarship applications through 6 April 2012.  Visit the conference web site for more information and to submit your applications,

Call for Applications: YECI Workshop on Statistical Methods - February 15, 2012

The OCTAVE Project, the South African MRC, HVTN and SCHARP are soliciting applications for a workshop  for YECIs on key statistical considerations for the design and analysis of HIV vaccine trials. Click the PDF below for more details.

 RFA: New OCTAVE Workshop for Young and Early Career

AIDS Vaccine 2012 Registration Now Open - February 10, 2012

Join us for AIDS Vaccine 2012 in Boston, 9 - 12 September 2012.  For additional details, visit

Enterprise Seeks Director of Secretariat - January 18, 2012

The Enterprise Board has begun recruiting qualified candidates to serve as Director of the Enterprise Secretariat; the job posting can be found on the Enterprise web site at  

AIDS Vaccine 2011 Wrap Up Report - January 6, 2012

The AIDS Vaccine 2011 conference was attended by more than 820 researchers, representing 45 countries, and among the highlights was the exciting discussion around the results of the two-year case-controlled studies of RV144.  

Correlates of Protection and HIV Vaccine Development - October 28, 2011

The Lancet published a piece on correlates of protection and HIV vaccine development in its November issue.  Click below to read the article.

AIDS Vaccine 2011 to Open in Bangkok - September 7, 2011

In the midst of the most promising era in HIV prevention research since the AIDS epidemic began, scientists from around the world will present more than 400 new studies outlining advances in the search for a safe and effective HIV vaccine at AIDS Vaccine 2011.  This global conference, the world’s only scientific meeting dedicated exclusively to HIV vaccine research, runs Monday, 12 September through Thursday, 15 September in Bangkok.  This is the first time that the annual AIDS Vaccine conference has been held in Asia.

Syndicate content
Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account